INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/17/22
Zantac lawsuit drop ‘not as significant as it appears' for GSK stock, analysts sayMarket Watch • 08/17/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/16/22
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/15/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the FirmBusiness Wire • 08/15/22
Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Investors of GSK plc - GSKNewsfile Corp • 08/13/22
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the FirmBusiness Wire • 08/12/22
GSK to 'vigorously defend' itself against claims stomach acid drug Zantac causes cancerProactive Investors • 08/12/22